Clinical Trials Directory

Trials / Completed

CompletedNCT04684004

Hyperglycemia in Patients With Takotsubo Syndrome

Blood Glucose Values at Hospital Admission and Clinical Outcomes in Patients With Takotsubo Syndrome: Hyperglycemia Effects on Heart Failure Events and Mortality at 24 Months of Follow-up

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Campania Luigi Vanvitelli · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

Patients with Takotsubo cardiomiopathy (TTC) have over-inflammation and over-sympathetic tone. However, these conditions could cause higher rate of heart failure (HF) events and deaths at 2 years of follow-up. Conversely, hyperglycemia vs. normoglycemia could result in over expression of inflammatory markers and catecholamines thta could result in higher rate of HF and deaths at 2 years of follow-up in TTC patients.

Conditions

Interventions

TypeNameDescription
OTHERTo report number of HF events and deathsIn these two cohorts of study authors will evaluate at 2 years of follow-up the number of HF events and of deaths.

Timeline

Start date
2013-01-01
Primary completion
2017-01-01
Completion
2019-01-01
First posted
2020-12-24
Last updated
2020-12-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04684004. Inclusion in this directory is not an endorsement.

Hyperglycemia in Patients With Takotsubo Syndrome (NCT04684004) · Clinical Trials Directory